The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
NTRK, RET, BRAF, and ALK fusions in thyroid fine-needle aspirates (FNAs).
 
Lori J. Wirth
Consulting or Advisory Role - Bayer; Blueprint Medicines; Eisai; Exelixis; Lilly; Loxo; Merck
Research Funding - Ayala Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); Eisai (Inst); Lilly (Inst)
Expert Testimony - Eisai
 
Mimi I-Nan Hu
Consulting or Advisory Role - Blueprint Medicines; Lilly; Loxo; Veracyte
 
Steven G. Waguespack
No Relationships to Disclose
 
Chrysoula Dosiou
No Relationships to Disclose
 
Paul Ladenson
Consulting or Advisory Role - Veracyte
 
Masha J. Livhits
No Relationships to Disclose
 
Peter M. Sadow
No Relationships to Disclose
 
Jeffrey Krane
No Relationships to Disclose
 
Brendan C. Stack
No Relationships to Disclose
 
Mark Zafereo
Consulting or Advisory Role - GeneproDx; Lilly; Merck
Research Funding - Lilly (Inst)
 
Syed Z. Ali
No Relationships to Disclose
 
Steven P Weitzman
No Relationships to Disclose
 
Yangyang Hao
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
 
Joshua Babiarz
No Relationships to Disclose
 
Giulia Kennedy
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
Patents, Royalties, Other Intellectual Property - Veracyte
 
Richard Kloos
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte